Astrazeneca Pharma India Ltd

Rediff.com » News » Astrazeneca Pharma India Ltd

News for Astrazeneca Pharma India Ltd

News
Business

Pfizer seeks approval in India for Covid vaccine

Pfizer India has become the first pharmaceutical firm to seek from the Drugs Controller General of India an emergency use authorisation for its COVID-19 vaccine in the country, after its parent......

PM to visit Serum Institute on Nov 28 to take stock of 'Covishield'

Prime Minister Narendra Modi will on Saturday visit the Pune-based Serum Institute of India (SII), which has partnered with global pharma giant AstraZeneca and the Oxford University for COVID-19......

Serum Inst gets DGCI notice over continuation of vaccine trial

The central drug regulator has issued a show-cause notice to the Serum Institute of India (SII) for not informing it about pharma giant AstraZeneca pausing the clinical trials of the Oxford vaccine......

3 COVID vaccines under active consideration: Health ministry

Three COVID-19 vaccines, developed by Bharat Biotech, Serum Institute of India and Pfizer, are under active consideration of India's drug regulator and there is hope that early licensure is......

COVID vaccine likely to be available by first of 2021: Choubey

If the advanced clinical trials of COVID-19 vaccine succeed, then an effective vaccination is likely to be available by the end of first quarter of 2021, Minister of State for Health Ashwini......

Big Pharma still betting on 'messed up' Indian drugs market

Global drugmakers have had a nauseous time in India's $14 billion market. Prices have dropped and valuable patents have been overruled as the authorities strive to make medicines affordable for the......

Make big money from open offers

A columnist, who is also a high-profile investment advisor, recently made a killing in the secondary market by selling shares of Wartsila India. What is so special about this? Wartsila's financial......

Ranbaxy can develop drugs at a 5th of global costs

Ranbaxy Laboratories Ltd, India's largest pharmaceuticals company, saidon Tuesday thatit could carry out new drug discovery research at one-fifth the cost of global pharmaceutical companies.While......

Govt regulations may lead to cheaper drugs in 2013

A new drug price control policy at long last, restrictions on multinationals taking over domestic firms and India cracking down on foreign firms' patents marked the year 2012 for the country's $22......

Pharma in 2014: Deals worth billions and fines worth millions

Even as private firms were busy stitching merger and partnership deals, the government also remained active during the year working on a separate policy to promote and strengthen domestic......

Rediff News

Astrazeneca Pharma India Ltd

News for Astrazeneca Pharma India Ltd

Pfizer seeks approval in India for Covid vaccine

PM to visit Serum Institute on Nov 28 to take stock of 'Covishield'

Serum Inst gets DGCI notice over continuation of vaccine trial

3 COVID vaccines under active consideration: Health ministry

COVID vaccine likely to be available by first of 2021: Choubey

Big Pharma still betting on 'messed up' Indian drugs market

Make big money from open offers

Ranbaxy can develop drugs at a 5th of global costs

Govt regulations may lead to cheaper drugs in 2013

Pharma in 2014: Deals worth billions and fines worth millions

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS